资讯
Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate ...
Adults who suffer from the common disorder are significantly more likely to express suicidal thoughts, concerning new ...
The global U.S. dermatology market size is calculated at USD 552.15 million in 2025 and is expected to reach around USD ...
First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...
Apollo Therapeutics, a biopharma company based in Cambridge and Oxford in the UK as well as Boston and Chicago in the US, has ...
Early onset atopic dermatitis and food allergy, among other factors, indicate greater risk for moderate to severe asthma in ...
Tight synthetics, sweat and chemicals in gymwear can trigger textile dermatitis, a skin allergy more common than most people ...
Dry skin around the nose, a common issue worsened by environmental factors and skin conditions, can be effectively managed ...
We all know the African shea tree is known for its moisturizing butter, but did you know its bark comes with surprising ...
Zacks Investment Research on MSN
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
Though Amgen AMGN and Viking Therapeutics VKTX do not currently market any obesity drugs, they are among the few biotechs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果